The company has already stockpiled about 50 million doses of the vaccine. The Serum Institute of India (SII) said on Sunday that it is ready to launch the Covishield vaccine in the country in the coming weeks after receiving approval from India’s drug regulator. The Pune-based vaccine specialist has started …
Read More »
India formally approved the Oxford-AstraZeneca on Sunday COVID-19 vaccine for emergency use. The vaccine, made in India by the Serum Institute, was first approved by Britain this week. This is all you need to know about the vaccine called Covishield in India. HOW DOES THE EFFECTIVENESS OF ASTRAZENECA SHOT APPEAR …
Read More »
AIIMS director Randeep Guleria said on Sunday that India will use only Oxford-AstraZeneca vaccines in the first phase of COVID-19 Bharat Biotech’s vaccination and Covaxin are just a backup in case the more infectious UK variant of the virus gets out of control. Both vaccines have received approval for emergency …
Read More »
The other vaccine, known as COVAXIN, has been developed locally by Bharat Biotech and the government-run Indian Council for Medical Research. Reuters, citing sources, reported on Friday that the injection could be approved, although little is known about the results of its clinical trials. “Granting permission for restricted use in …
Read More »
Dr. Vinod Paul, NITI Aayog member and head of the COVID-19 Working group said on Friday that the government will inoculate 30 million people belonging to priority groups in the first phase of its vaccination campaign. In the next 6 to 8 months, front-line workers, especially those working in healthcare …
Read More »
Coronavirus News LIVE Updates: India is holding nationwide drills today to kick off one of the world’s largest coronavirus vaccination programs as the drug regulator prepared to approve the first vaccine. A government panel on Friday recommended the emergency use of the AstraZeneca-Oxford University injection and the first injections could …
Read More »
The National Medicines Regulator’s Committee of Subject Matters (SEC) will meet again on Friday to make a decision on the Serum Institute of India (SII) Oxford-AstraZeneca’s Emergency Use Authorization Application (EUA) and Candidate Bharat Biotech vaccines against coronavirus disease. (COVID-19). The SEC had met for a second time on Wednesday …
Read More »
India is likely to get a coronavirus disease (Covid-19) vaccine in the New Year, the country’s top drug regulator hinted during a webinar on the science behind the vaccine’s development that allowed it to arrive from the lab. to people in less than 12 months. “We will have a Happy …
Read More »
NEW DELHI: India is preparing to launch the Covid-19 vaccine across the country and a two-day trial is currently underway in Andhra Pradesh, Assam, Gujarat, and Punjab. Oxford-AstraZeneca’s front-runner is already under regulatory review and sources have indicated that approval for emergency use may arrive in the next few days. …
Read More »
NEW DELHI: The Serum Institute of India said on Monday it has already produced nearly 50 million doses of the Oxford-AstraZeneca Covid-19 vaccine and awaits emergency use approval from Indian and UK regulators in the ” next days”. “You will hear good news from the UK very soon,” Serum CEO …
Read More »